ABI offers affordable: Research, Biotech, Pharmaceutical novel compound synthesis needs: Contract Research, Rapid Synthesis, Small to Large Scale Manufacturing, Drug intermediates (N-1, N-2)
At ABI we specialize in innovative small and large molecule synthesis to meet your research, biotech, pharmaceutical, drug intermediates and final drug synthesis needs. Our team of experienced scientists work together to accomplish the synthesis of any challenging target at any scale, ranging from milligrams to tons levels at competitive pricing and unparalleled quality. Project planning and regular communication ensure that customer expectations of quality and delivery are met.
ABI is dedicated to continuously developing new synthetic methodologies, optimization of existing synthetic pathways and development of specialty reagents to maintain a competitive edge and improve cost efficiency for our customers. We undertake an exhaustive literature search to access feasibility of target molecule synthesis thereby saving you invaluable time and resources. We commit only to proceed with feasible target molecule synthesis with the uttermost confidentiality and strive to meet customer delivery timeline. Our project dedicated team will constantly communicate with you on progress, intermediate compound synthesis stage, and final sample availability
We pride ourselves in 99% completion of undertaken projects, we deliver building blocks, tag molecules, intermediates, small molecules, reference compounds and novel reagents. Our highly experienced team deploys innovative as well as state of the art chemistry to rapidly synthesize any challenging molecule in cost effective manner. We specialize in aliphatic, aromatic, heterocyclic, boronic acid/ester, carbohydrate, and peptide synthesis. We have experience and expertise having previously synthesized the following compounds: FDA approved drugs, and drugs under clinical trials, drug metabolites, impurities, proprietary designed molecules, fine chemicals, specialty chemicals, stable isotopic labelled products (SILAC), chiral intermediates, analysis, chiral separation and final products with high enantiomeric access, pharmaceutical API and bulk intermediates.
To initiate your project planning and feasibility inquiry today, please send an email to orders@americanbioinnovations.com and our dedicated team of synthesis scientists will initiate a personalized and confidential quote process.
At ABI we specialize in innovative small and large molecule synthesis to meet your research, biotech, pharmaceutical, drug intermediates and final drug synthesis needs. Our team of experienced scientists work together to accomplish the synthesis of any challenging target at any scale, ranging from milligrams to tons levels at competitive pricing and unparalleled quality. Project planning and regular communication ensure that customer expectations of quality and delivery are met.
ABI is dedicated to continuously developing new synthetic methodologies, optimization of existing synthetic pathways and development of specialty reagents to maintain a competitive edge and improve cost efficiency for our customers. We undertake an exhaustive literature search to access feasibility of target molecule synthesis thereby saving you invaluable time and resources. We commit only to proceed with feasible target molecule synthesis with the uttermost confidentiality and strive to meet customer delivery timeline. Our project dedicated team will constantly communicate with you on progress, intermediate compound synthesis stage, and final sample availability
We pride ourselves in 99% completion of undertaken projects, we deliver building blocks, tag molecules, intermediates, small molecules, reference compounds and novel reagents. Our highly experienced team deploys innovative as well as state of the art chemistry to rapidly synthesize any challenging molecule in cost effective manner. We specialize in aliphatic, aromatic, heterocyclic, boronic acid/ester, carbohydrate, and peptide synthesis. We have experience and expertise having previously synthesized the following compounds: FDA approved drugs, and drugs under clinical trials, drug metabolites, impurities, proprietary designed molecules, fine chemicals, specialty chemicals, stable isotopic labelled products (SILAC), chiral intermediates, analysis, chiral separation and final products with high enantiomeric access, pharmaceutical API and bulk intermediates.
To initiate your project planning and feasibility inquiry today, please send an email to orders@americanbioinnovations.com and our dedicated team of synthesis scientists will initiate a personalized and confidential quote process.